Temporal determinants of tumour response to neoadjuvant rectal radiotherapy

• Published in: PloS one Vol. 16; no. 6; p. e0254018
• Main Authors: Koo, Kendrick, Ward, Rachel, Smith, Ryan L, Ruben, Jeremy, Carne, Peter W. G, Elsaleh, Hany
• Format: Journal Article
• Language: English
• Published: San Francisco Public Library of Science 30-06-2021; Public Library of Science (PLoS)
• Subjects: Adenocarcinoma; Biology and Life Sciences; Cancer; Cancer therapies; Care and treatment; Cell cycle; Chemotherapy; Circadian rhythm; Colorectal cancer; Complications and side effects; Endoscopy; Head & neck cancer; Literature reviews; Medicine and Health Sciences; Meta-analysis; Neoadjuvant therapy; Oncology; Patient outcomes; Patients; Radiation therapy; Rectum; Regression; Statistical analysis; Surgery; Survival analysis; Tumors; Ultrasonic imaging; Australia; Victoria Australia
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0254018

In locally advanced rectal cancer, longer delay to surgery after neoadjuvant radiotherapy increases the likelihood of histopathological tumour response. Chronomodulated radiotherapy in rectal cancer has recently been reported as a factor increasing tumour response to neoadjuvant treatment in patients having earlier surgery, with patients receiving a larger proportion of afternoon treatments showing improved response. This paper aims to replicate this work by exploring the impact of these two temporal factors, independently and in combination, on histopathological tumour response in rectal cancer patients. A retrospective review of all patients with rectal adenocarcinoma who received long course ([greater than or equal to]24 fractions) neoadjuvant radiotherapy with or without chemotherapy at a tertiary referral centre was conducted. Delay to surgery and radiotherapy treatment time were correlated to clinicopathologic characteristics with a particular focus on tumour regression grade. A review of the literature and meta-analysis were also conducted to ascertain the impact of time to surgery from preoperative radiotherapy on tumour regression. From a cohort of 367 patients, 197 patients met the inclusion criteria. Complete pathologic response (AJCC regression grade 0) was seen in 46 (23%) patients with a further 44 patients (22%) having at most small groups of residual cells (AJCC regression grade 1). Median time to surgery was 63 days, and no statistically significant difference was seen in tumour regression between patients having early or late surgery. There was a non-significant trend towards a larger proportion of morning treatments in patients with grade 0 or 1 regression (p = 0.077). There was no difference in tumour regression when composite groups of the two temporal variables were analysed. Visualisation of data from 39 reviewed papers (describing 27379 patients) demonstrated a plateau of response to neoadjuvant radiotherapy after approximately 60 days, and a meta-analysis found improved complete pathologic response in patients having later surgery. There was no observed benefit of chronomodulated radiotherapy in our cohort of rectal cancer patients. Review of the literature and meta-analysis confirms the benefit of delayed surgery, with a plateau in complete response rates at approximately 60-days between completion of radiotherapy and surgery. In our cohort, time to surgery for the majority of our patients lay along this plateau and this may be a more dominant factor in determining response to neoadjuvant therapy, obscuring any effects of chronomodulation on tumour response. We would recommend surgery be performed between 8 and 11 weeks after completion of neoadjuvant radiotherapy in patients with locally advanced rectal cancer.